Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

Matthias Briel, Melanie Lane, Victor M. Montori, Dirk Bassler, Paul Glasziou, German Malaga, Elie A. Akl, Ignacio Ferreira-Gonzalez, Pablo Alonso-Coello, Gerard Urrutia, Regina Kunz, Carolina Ruiz Culebro, Suzana Alves da Silva, David N. Flynn, Mohamed B. Elamin, Brigitte Strahm, Mohammad Hassan Murad, Benjamin Djulbegovic, Neill K.J. Adhikari, Edward J. MillsFemida Gwadry-Sridhar, Haresh Kirpalani, Heloisa P. Soares, Nisrin O. Abu Elnour, John J. You, Paul J. Karanicolas, Heiner C. Bucher, Julianna F. Lampropulos, Alain J. Nordmann, Karen E.A. Burns, Sohail M. Mulla, Heike Raatz, Amit Sood, Jagdeep Kaur, Clare R. Bankhead, Rebecca J. Mullan, Kara A. Nerenberg, Per Olav Vandvik, Fernando Coto-Yglesias, Holger Schünemann, Fabio Tuche, Pedro Paulo M. Chrispim, Deborah J. Cook, Kristina Lutz, Christine M. Ribic, Noah Vale, Patricia J. Erwin, Rafael Perera, Qi Zhou, Diane Heels-Ansdell, Tim Ramsay, Stephen D. Walter, Gordon H. Guyatt

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)'. Together they form a unique fingerprint.

Medicine & Life Sciences